HEPARIN - MECHANISM OF ACTION, PHARMACOKINETICS, DOSING CONSIDERATIONS, MONITORING, EFFICACY, AND SAFETY

被引：42

作者：

HIRSH, J

DALEN, JE

DEYKIN, D

POLLER, L

机构：

[1] UNIV ARIZONA, COLL MED, TUCSON, AZ 85721 USA

[2] VET ADM MED CTR JAMAICA PLAIN, BOSTON, MA 02130 USA

[3] WITHINGTON HOSP, NAT REFERENCE LAB ANTICOAGULANT REAGENT & CONTROL, MANCHESTER M20 8LR, LANCS, ENGLAND

来源：

CHEST | 1992年 / 102卷 / 04期

关键词：

D O I：

10.1378/chest.102.4.337S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：S337 / S351

页数：15

共 225 条

[1]

AARSKOG D, 1980, LANCET, V2, P650

[2]

ABBOTT EC, 1966, CAN MED ASSOC J, V94, P1155

[3]

AMBRUS JL, 1978, RES COMMUN CHEM PATH, V22, P3

[4] MOLECULAR-WEIGHT DEPENDENCY OF THE HEPARIN POTENTIATED INHIBITION OF THROMBIN AND ACTIVATED FACTOR-X - EFFECT OF HEPARIN NEUTRALIZATION IN PLASMA [J].

ANDERSSON, LO ;

BARROWCLIFFE, TW ;

HOLMER, E ;

JOHNSON, EA ;

SODERSTROM, G .

THROMBOSIS RESEARCH, 1979, 15 (3-4) :531-541

[5]

ANDRIUOLI G, 1985, HAEMOSTASIS, V15, P324

[6]

ANSELL J, 1980, THROMB HAEMOSTASIS, V43, P61

[7] CONTRIBUTION OF 3-O-SULFATED AND 6-O-SULFATED GLUCOSAMINE RESIDUES IN THE HEPARIN-INDUCED CONFORMATIONAL CHANGE IN ANTITHROMBIN-III [J].

ATHA, DH ;

LORMEAU, JC ;

PETITOU, M ;

ROSENBERG, RD ;

CHOAY, J .

BIOCHEMISTRY, 1987, 26 (20) :6454-6461

[8]

Avioli L V, 1975, Adv Exp Med Biol, V52, P375

[9] HEPARIN-INDUCED IMMUNE THROMBOCYTOPENIA [J].

BABCOCK, RB ;

DUMPER, W ;

SCHARFMAN, WB .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (05) :237-241

[10] ARTERIAL THROMBOEMBOLISM IN PATIENTS RECEIVING SYSTEMIC HEPARIN THERAPY - COMPLICATION ASSOCIATED WITH HEPARIN-INDUCED THROMBOCYTOPENIA [J].

BAIRD, RA ;

CONVERY, FR .

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1977, 59 (08) :1061-1064

← 1 2 3 4 5 6 7 8 9 10 →